AR and prostate carcinoma: Furthermore, SQLE overexpression demonstrates prognostic significance in advanced prostate cancer, where miR-205-mediated SQLE downregulation effectively suppresses de novo cholesterol synthesis, cellular proliferation, and resistance to next-generation androgen receptor inhibitors [58].